Suppr超能文献

相似文献

1
Impact of day-to-day variation in FEV1 on measures of change: A conceptual description.
J Cyst Fibros. 2024 Sep;23(5):943-946. doi: 10.1016/j.jcf.2024.07.005. Epub 2024 Aug 14.
2
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.
Cochrane Database Syst Rev. 2025 Jan 20;1(1):CD009730. doi: 10.1002/14651858.CD009730.pub3.
3
Exercise versus airway clearance techniques for people with cystic fibrosis.
Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2.
4
Nebulised hypertonic saline for cystic fibrosis.
Cochrane Database Syst Rev. 2018 Sep 27;9(9):CD001506. doi: 10.1002/14651858.CD001506.pub4.
5
Short-acting inhaled bronchodilators for cystic fibrosis.
Cochrane Database Syst Rev. 2022 Jun 24;6(6):CD013666. doi: 10.1002/14651858.CD013666.pub2.
6
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Cochrane Database Syst Rev. 2024 May 3;5(5):CD009530. doi: 10.1002/14651858.CD009530.pub5.
7
Macrolide antibiotics (including azithromycin) for cystic fibrosis.
Cochrane Database Syst Rev. 2024 Feb 27;2(2):CD002203. doi: 10.1002/14651858.CD002203.pub5.
8
9
Nebulised hypertonic saline for cystic fibrosis.
Cochrane Database Syst Rev. 2023 Jun 14;6(6):CD001506. doi: 10.1002/14651858.CD001506.pub5.
10
Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.
Cochrane Database Syst Rev. 2023 May 5;5(5):CD002011. doi: 10.1002/14651858.CD002011.pub3.

引用本文的文献

1
Natural variability of lung function in primary ciliary dyskinesia: longitudinal analysis from the PROVALF-PCD cohort.
ERJ Open Res. 2025 Jun 23;11(3). doi: 10.1183/23120541.01115-2024. eCollection 2025 May.
2
Baseline-dependent improvement in CF studies, plausibility of bias.
Contemp Clin Trials Commun. 2024 Oct 5;42:101378. doi: 10.1016/j.conctc.2024.101378. eCollection 2024 Dec.

本文引用的文献

4
Long-term effectiveness of dual CFTR modulator treatment of cystic fibrosis.
ERJ Open Res. 2022 Nov 14;8(4). doi: 10.1183/23120541.00204-2022. eCollection 2022 Oct.
5
A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis.
J Cyst Fibros. 2022 Jan;21(1):78-83. doi: 10.1016/j.jcf.2021.08.013. Epub 2021 Aug 31.
6
Paediatric reproducibility limits for the forced expiratory volume in 1 s.
Thorax. 2020 Oct;75(10):891-896. doi: 10.1136/thoraxjnl-2020-214817. Epub 2020 Aug 11.
7
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.
N Engl J Med. 2019 Nov 7;381(19):1809-1819. doi: 10.1056/NEJMoa1908639. Epub 2019 Oct 31.
9
Use of FEV in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher.
J Cyst Fibros. 2017 May;16(3):318-326. doi: 10.1016/j.jcf.2017.01.002. Epub 2017 Jan 20.
10
A systematic review of studies examining the rate of lung function decline in patients with cystic fibrosis.
Paediatr Respir Rev. 2016 Sep;20:55-66. doi: 10.1016/j.prrv.2016.03.002. Epub 2016 Mar 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验